Big pharmaceutical firms now rank China as the best location for conducting R&D in Asia. Martin Mackay, president at Pfizer PharmaTheraputics Research & Development, tells CNBC's Martin Soong, Sri Jegarajah & Karen Tso how it is tapping into the talent there.
Topics:
Pharmaceuticals | Asia | Pharmaceuticals
COMMENTS
Thank you for joining our discussion. Your comment has been posted.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT